Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
$26.24
+0.4%
$26.14
$24.29
$27.33
$1.26B0.22377,083 shs81,509 shs
Best Buy Co., Inc. stock logo
BBY
Best Buy
$84.82
+4.0%
$76.16
$62.30
$86.11
$18.35B1.52.97 million shs9.81 million shs
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
$4.75
+5.8%
$0.71
$0.19
$2.65
$4.06M3.081.39 million shs57,017 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
0.00%0.00%+1.14%-1.32%-1.54%
Best Buy Co., Inc. stock logo
BBY
Best Buy
0.00%+18.63%+17.12%+8.86%+16.72%
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
+5.69%+1,456.38%+1,165.44%+1,104.42%+1,220.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Best Buy Co., Inc. stock logo
BBY
Best Buy
4.5136 of 5 stars
2.22.05.01.53.32.52.5
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
0.00
N/AN/AN/A
Best Buy Co., Inc. stock logo
BBY
Best Buy
2.36
Hold$86.361.81% Upside
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
2.00
HoldN/AN/A

Current Analyst Ratings

Latest BBY, HILS, BAB, and MGNS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/31/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$90.00 ➝ $95.00
5/31/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$87.00 ➝ $86.00
5/31/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$80.00 ➝ $90.00
5/30/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$95.00 ➝ $95.00
5/28/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$85.00 ➝ $85.00
5/23/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$95.00 ➝ $95.00
5/7/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSell ➝ Sell$76.00 ➝ $67.00
4/8/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy$95.00 ➝ $94.00
3/22/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$89.00 ➝ $101.00
3/20/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$85.00 ➝ $95.00
(Data available from 6/2/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
N/AN/AN/AN/AN/AN/A
Best Buy Co., Inc. stock logo
BBY
Best Buy
$43.45B0.42$10.75 per share7.89$14.24 per share5.96
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/A$0.48 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Best Buy Co., Inc. stock logo
BBY
Best Buy
$1.24B$5.7114.8512.472.542.90%47.56%9.05%9/3/2024 (Estimated)
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
-$8.47M-$0.72N/AN/AN/AN/A-188.44%-149.61%N/A

Latest BBY, HILS, BAB, and MGNS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/30/2024Q1 25
Best Buy Co., Inc. stock logo
BBY
Best Buy
$1.08$1.20+$0.12$1.27$8.96 billion$8.85 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
$0.883.35%N/AN/AN/A
Best Buy Co., Inc. stock logo
BBY
Best Buy
$3.764.43%+18.71%65.85%21 Years
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/AN/AN/AN/AN/A

Latest BBY, HILS, BAB, and MGNS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/30/2024
Best Buy Co., Inc. stock logo
BBY
Best Buy
quarterly$0.945.23%6/20/20246/20/20247/11/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
N/AN/AN/A
Best Buy Co., Inc. stock logo
BBY
Best Buy
0.37
1.01
0.37
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
N/A
3.01
3.01

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
N/A
Best Buy Co., Inc. stock logo
BBY
Best Buy
80.96%
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
13.36%

Insider Ownership

CompanyInsider Ownership
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
N/A
Best Buy Co., Inc. stock logo
BBY
Best Buy
0.59%
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
30.24%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Invesco Taxable Municipal Bond ETF stock logo
BAB
Invesco Taxable Municipal Bond ETF
N/A47.90 millionN/ANot Optionable
Best Buy Co., Inc. stock logo
BBY
Best Buy
85,000216.35 million215.08 millionOptionable
Hillstream BioPharma, Inc. stock logo
HILS
Hillstream BioPharma
117.60 million12.28 millionNot Optionable

BBY, HILS, BAB, and MGNS Headlines

Recent News About These Companies

Hillstream BioPharma (NASDAQ:HILS) Shares Down 7.2%
Hill & Smith PLC HILS
Kiromic BioPharma Inc Ordinary Shares KRBP
NMTRQ 9 Meters Biopharma, Inc.
HILS - Hillstream BioPharma, Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Invesco Taxable Municipal Bond ETF logo

Invesco Taxable Municipal Bond ETF

NYSEARCA:BAB
PowerShares Build America Bond Portfolio (the Fund) seeks investment results that correspond generally to the price and yield performance of an index called The BofA Merrill Lynch Build America Bond Index (the Index). The Fund will normally invests at least 80% of its total assets in the securities that comprise the Index. The Index is designed to track the performance of the United States dollar-denominated Build America Bonds publicly issued by the United States and territories, and their political subdivisions, in the United States market. The investment advisor of the Company is Invesco PowerShares Capital Management LLC.
Best Buy logo

Best Buy

NYSE:BBY
Best Buy Co., Inc. engages in the retail of technology products in the United States, Canada, and international. Its stores provide computing and mobile phone products, such as desktops, notebooks, and peripherals; mobile phones comprising related mobile network carrier commissions; networking products; tablets covering e-readers; smartwatches; and consumer electronics consisting of digital imaging, health and fitness products, portable audio comprising headphones and portable speakers, and smart home products, as well as home theaters, which includes home theater accessories, soundbars, and televisions. The company's stores also offer appliances, such as dishwashers, laundry, ovens, refrigerators, blenders, coffee makers, vacuums, and personal care; entertainment products consisting of drones, peripherals, movies, and toys, as well as hardware and software, and virtual reality and other software products; and other products, such as baby, food and beverage, luggage, outdoor living, and sporting goods. In addition, it provides delivery, installation, memberships, repair, set-up, technical support, health-related, and warranty-related services. The company offers its products through stores and websites under the Best Buy, Best Buy Ads, Best Buy Business, Best Buy Health, Buy Mobile, CST, Current Health, Geek Squad, Lively, Magnolia, Pacific Kitchen, Home, TechLiquidators, and Yardbird brands, as well as domain names comprising bestbuy.com, currenthealth.com, lively.com, techliquidators.com, yardbird.com, and bestbuy.ca. The company was formerly known as Sound of Music, Inc. Best Buy Co., Inc. was incorporated in 1966 and is headquartered in Richfield, Minnesota.
Hillstream BioPharma logo

Hillstream BioPharma

NASDAQ:HILS
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.